During a recent interview, Bae-Jin Lee, CEO of Marine Bioprocess and a prominent research scientist with a Ph.D. in marine food engineering, shared insights into the company’s significant achievements in scientific research and innovation. Under his leadership, Marine Bioprocess has reached new heights, particularly with the development of a groundbreaking microplastic-free salt fermented with Lactobacillus, showing positive effects on blood pressure. This product exemplifies the company’s relentless dedication and innovative spirit.
Mr. Lee discussed the challenges faced along the way, including navigating the aftermath of a bankrupt manufacturing company during the Korean International Monetary Fund crisis in the 1990s and addressing market indifference. Despite these obstacles, the company persevered, achieving technological advancements like the development of amino acid-infused soluble calcium from tuna fish bones and a low-sodium salt to reduce sodium intake and lower high blood pressure. However, both products encountered commercial challenges, particularly regarding pricing.
